Abiopharma

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

ASML reports transactions under its current share buyback program

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

NiCE World 2026: Where Agentic AI Meets Enterprise Scale

U.S. Marine Corps Expands Autonomous Fires Capability with Oshkosh Defense ROGUE-Fires Block 2 Award

OpenPayd Targets Nasdaq Listing at Unicorn Valuation

Optimum Launches Effort to Drive a Consensual Repositioning of its Capital Structure

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Rapid7 Appoints Wael Mohamed Chief Executive Officer; Corey Thomas to Become Executive Chairman

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 Per Share for June 2026